---
title: "Teladoc (TDOC) Gets a Hold from UBS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286568783.md"
description: "UBS analyst Kevin Caliendo has maintained a Hold rating on Teladoc (TDOC) with a price target of $6.00. Caliendo, a 4-star analyst, has an average return of 3.5% and a 53.71% success rate. Previously, Citi's Daniel Grosslight also issued a Hold rating, while Canaccord Genuity maintained a Buy rating on April 30."
datetime: "2026-05-15T12:41:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286568783.md)
  - [en](https://longbridge.com/en/news/286568783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286568783.md)
---

# Teladoc (TDOC) Gets a Hold from UBS

UBS analyst Kevin Caliendo maintained a Hold rating on Teladoc today and set a price target of $6.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Caliendo is a 4-star analyst with an average return of 3.5% and a 53.71% success rate. Caliendo covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Cencora, and Henry Schein.

In addition to UBS, Teladoc also received a Hold from Citi’s Daniel Grosslight in a report issued on May 5. However, on April 30, Canaccord Genuity maintained a Buy rating on Teladoc (NYSE: TDOC).

### Related Stocks

- [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md)
- [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md)
- [EDOC.US](https://longbridge.com/en/quote/EDOC.US.md)
- [FDHT.US](https://longbridge.com/en/quote/FDHT.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [XRAY.US](https://longbridge.com/en/quote/XRAY.US.md)
- [COR.US](https://longbridge.com/en/quote/COR.US.md)
- [HSIC.US](https://longbridge.com/en/quote/HSIC.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)](https://longbridge.com/en/news/286944473.md)
- [Teladoc Health extends rally to seventh straight session, gaining 22%](https://longbridge.com/en/news/285764179.md)
- [Teladoc Health (TDOC) Projected to Post Earnings on Wednesday](https://longbridge.com/en/news/283641357.md)
- [Endo GUC Trust Provides Its First Quarter 2026 Report](https://longbridge.com/en/news/286622222.md)
- [Activist Pineal Capital pushes Teladoc to consider split, other changes to boost value](https://longbridge.com/en/news/281248662.md)